News | January 30, 2015

Australian Comprehensive Cancer Center Switches to Elekta's Mosaiq Oncology Information System

Open system give centers flexibility to integrate existing systems

Radiation therapy, Elekta, Mosaiq, OIS

Image courtesy of Elekta

Radiation therapy, Elekta, Mosaiq, OIS

Image courtesy of Elekta

January 30, 2015 — The conversion to Elekta's Mosaiq oncology information systems (OIS) for radiation oncology, hematology/medical oncology and pediatric oncology at the Queen Elizabeth II Medical Centre (QEIIMC), Perth, WA, will occur in stages from mid-2015 to 2016 as part of consolidating the cancer care of four Western Australian public services into a single, multi-disciplinary facility.

The consolidation comprises the Sir Charles Gairdner Hospital, Princess Margaret Hospital and the new Children's Hospital.

Today, more than two thirds of radiation oncology departments in Australia rely on Mosaiq OIS. Officials at the four clinics spent several months evaluating many of these departments and their use of Mosaiq – both its features and its performance. In addition to compatibility with virtually all linear accelerators (linacs), including the medical center's Varian linacs and a CyberKnife treatment system, the following aspects of Elekta and Mosaiq were critical in their decision to change to a new OIS, according to Andrew Wilson, managing director of Elekta Australia:

·       Elekta support for Mosaiq in Australia

·       Pharmaceutical benefits scheme supported by Mosaiq

·       Available billing system interface available with Mosaiq

·       Patient scheduling and tracking system interface available  with Mosaiq

·       Comprehensive training on Mosaiq available

·       Analytiq, Elekta's data analysis tool for data mining and decision support

·       Availability of data migration

For more information:



Related Content

News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
Mercy Signs Multi-System, Multi-Hospital Agreement for Accuray Radiotherapy Systems
News | Radiation Therapy | May 16, 2018
Accuray Inc. signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact and...
ViewRay Unveils New Soft Tissue Visualization Technologies for MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | April 30, 2018
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.
Technology | Quality Assurance (QA) | April 27, 2018
Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality...
RayStation Users Win Inaugural Treatment Planning World Championships
News | Treatment Planning | April 27, 2018
In the first World Championships of Treatment Planning, arranged by radiation oncology analytics company ProKnow and...
Brainlab Introduces New Hi-Res Planning Algorithm for VersaHD
News | Treatment Planning | April 24, 2018
Brainlab announced the implementation of a software solution that can achieve better radiation dose conformity around...
Shorter Radiotherapy Courses Safe and Effective for Prostate Cancer
News | Prostate Cancer | April 23, 2018
Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate cancer patients,...
Elekta Expands Mosaiq Oncology Information System With PalabraApps
News | Oncology Information Management Systems (OIMS) | April 20, 2018
April 20, 2018 — Elekta announced that it is making a strategic investment in PalabraApps LLC to advance the developm
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Overlay Init